• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间日疟原虫新鲜分离株的体外敏感性评估。

Assessment of in vitro sensitivity of Plasmodium vivax fresh isolates.

作者信息

Muhamad Poonuch, Chacharoenkul Wanna, Rungsihirunrat Kanchana, Ruengweerayut Ronnatrai, Na-Bangchang Kesara

机构信息

Pharmacology and Toxicology Unit, Graduate Program in Biomedical Sciences, Thammasat University, Thailand.

出版信息

Asian Pac J Trop Biomed. 2011 Jan;1(1):49-53. doi: 10.1016/S2221-1691(11)60067-1.

DOI:10.1016/S2221-1691(11)60067-1
PMID:23569724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3609160/
Abstract

OBJECTIVE

To compare the applicability of the SYBR Green-I assay with the standard schizont maturation assay, for determination of sensitivity of Plasmodium vivax (P. vivax) to chloroquine and a new antifolate WR 99210.

METHODS

The study was conducted at Mae Tao Clinic for migrant workers, Tak Province during April 2009 to July 2010. A total of 64 blood samples (1 mL blood collected into sodium heparinized plastic tube) were collected from patients with mono-infection with P. vivax malaria prior to treatment with standard regimen of a 3-day chloroquine. In vitro sensitivity of P. vivax isolates was evaluated by schizont maturation inhibition and SYBR Green-I assays.

RESULTS

A total of 30 out of 64 blood samples collected from patients with P. vivax malaria were successfully analyzed using both the microscopic schizont maturation inhibition and SYBR Green-I assays. The failure rates of the schizont maturation inhibition assay (50%) and the SYBR Green-I assay (54%) were similar (P=0.51). The median IC10s, IC50s and IC90s of both chloroquine and WR99210 were not significantly different from the clinical isolates of P. vivax tested. Based on the cut-off of 100 nM, the prevalences of chloroquine resistance determined by schizont maturation inhibition and SYBR Green-I assays were 19 and 11 isolates, respectively. The strength of agreement between the two methods was very poor for both chloroquine and WR99210.

CONCLUSIONS

On the basis of this condition and its superior sensitivity, the microscopic method appears better than the SYBR Green-I Green assay for assessing in vitro sensitivity of fresh P. vivax isolates to antimalarial drugs.

摘要

目的

比较SYBR Green-I检测法与标准裂殖体成熟检测法在测定间日疟原虫对氯喹和新型抗叶酸药物WR 99210敏感性方面的适用性。

方法

研究于2009年4月至2010年7月在北碧府为农民工开设的湄索诊所进行。在用3日氯喹标准疗法治疗前,从单纯感染间日疟原虫的患者中总共采集了64份血样(1毫升血液收集到含肝素钠的塑料试管中)。通过裂殖体成熟抑制试验和SYBR Green-I检测法评估间日疟原虫分离株的体外敏感性。

结果

从间日疟原虫患者采集的64份血样中,共有30份成功通过显微镜下裂殖体成熟抑制试验和SYBR Green-I检测法进行了分析。裂殖体成熟抑制试验(50%)和SYBR Green-I检测法(54%)的失败率相似(P=0.51)。氯喹和WR99210的IC10、IC50和IC90中位数与所检测的间日疟原虫临床分离株无显著差异。基于100 nM的临界值,通过裂殖体成熟抑制试验和SYBR Green-I检测法确定的氯喹耐药率分别为19株和11株。两种方法在氯喹和WR99210方面的一致性都很差。

结论

基于这种情况及其更高的敏感性,在评估新鲜间日疟原虫分离株对抗疟药物的体外敏感性方面,显微镜检测法似乎优于SYBR Green-I检测法。

相似文献

1
Assessment of in vitro sensitivity of Plasmodium vivax fresh isolates.间日疟原虫新鲜分离株的体外敏感性评估。
Asian Pac J Trop Biomed. 2011 Jan;1(1):49-53. doi: 10.1016/S2221-1691(11)60067-1.
2
Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.2009-2010 年泰缅边境地区间日疟原虫对氯喹的临床疗效和体外敏感性监测。
Malar J. 2011 Feb 16;10:44. doi: 10.1186/1475-2875-10-44.
3
Plasmodium vivax trophozoites insensitive to chloroquine.间日疟原虫滋养体对氯喹不敏感。
Malar J. 2008 May 27;7:94. doi: 10.1186/1475-2875-7-94.
4
Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand.间日疟原虫耐药基因;泰国疟疾流行地区与氯喹敏感性相关的Pvmdr1和Pvcrt-o基因多态性
Korean J Parasitol. 2015 Feb;53(1):43-9. doi: 10.3347/kjp.2015.53.1.43. Epub 2015 Feb 27.
5
In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.哥伦比亚间日疟原虫对抗疟药的体外敏感性
Antimicrob Agents Chemother. 2014 Nov;58(11):6354-9. doi: 10.1128/AAC.03191-14. Epub 2014 Aug 11.
6
Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes.中缅边境地区间日疟原虫分离株的体外药敏试验及与 Pvmdr1 和 Pvcrt-o 基因多态性的关系。
PLoS Negl Trop Dis. 2020 Jun 12;14(6):e0008255. doi: 10.1371/journal.pntd.0008255. eCollection 2020 Jun.
7
Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic.在间日疟原虫流行地区,用于测定新鲜人血中间日疟原虫分离株对抗疟药敏感性的简单体外试验。
Antimicrob Agents Chemother. 2003 Jan;47(1):170-3. doi: 10.1128/AAC.47.1.170-173.2003.
8
Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates.间日疟原虫:用于测量新鲜和冷冻保存分离株中氯喹敏感性的同位素、PicoGreen 和显微镜检测法。
Exp Parasitol. 2006 Sep;114(1):34-9. doi: 10.1016/j.exppara.2006.02.006. Epub 2006 Mar 20.
9
Determinants of in vitro drug susceptibility testing of Plasmodium vivax.间日疟原虫体外药物敏感性试验的决定因素
Antimicrob Agents Chemother. 2008 Mar;52(3):1040-5. doi: 10.1128/AAC.01334-07. Epub 2008 Jan 7.
10
Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.恶性疟原虫和间日疟原虫表现出相反的氯喹抗性逆转表型。
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00355-17. Print 2017 Aug.

引用本文的文献

1
Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.在墨西哥南部开展的一项开放性、非随机临床试验中,比较氯喹和伯氨喹联合治疗14天与间歇性单剂量疗法消除间日疟原虫的有效性。
Malar J. 2015 Oct 30;14:426. doi: 10.1186/s12936-015-0938-2.
2
Effect of insulin on Blattela germanica Linnacus.胰岛素对德国小蠊的影响。
Asian Pac J Trop Biomed. 2011 Aug;1(4):285-8. doi: 10.1016/S2221-1691(11)60044-0.

本文引用的文献

1
A framework for assessing the feasibility of malaria elimination.疟疾消除可行性评估框架
Malar J. 2010 Nov 11;9:322. doi: 10.1186/1475-2875-9-322.
2
Artemisinin resistance: current status and scenarios for containment.青蒿素耐药性:现状和遏制情景。
Nat Rev Microbiol. 2010 Apr;8(4):272-80. doi: 10.1038/nrmicro2331. Epub 2010 Mar 8.
3
Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.疟疾化疗的现状以及药理学在抗疟药物研发中的作用。
Fundam Clin Pharmacol. 2009 Aug;23(4):387-409. doi: 10.1111/j.1472-8206.2009.00709.x.
4
Resistance to therapies for infection by Plasmodium vivax.间日疟原虫感染治疗的耐药性。
Clin Microbiol Rev. 2009 Jul;22(3):508-34. doi: 10.1128/CMR.00008-09.
5
Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates.基于SYBR Green I的检测方法用于恶性疟原虫临床分离株药敏常规监测的性能与可靠性
Trans R Soc Trop Med Hyg. 2008 Apr;102(4):346-51. doi: 10.1016/j.trstmh.2008.01.021. Epub 2008 Mar 5.
6
Determinants of in vitro drug susceptibility testing of Plasmodium vivax.间日疟原虫体外药物敏感性试验的决定因素
Antimicrob Agents Chemother. 2008 Mar;52(3):1040-5. doi: 10.1128/AAC.01334-07. Epub 2008 Jan 7.
7
Cultivation of Plasmodium vivax.间日疟原虫的培养
Trends Parasitol. 2008 Feb;24(2):85-8. doi: 10.1016/j.pt.2007.09.010. Epub 2008 Jan 3.
8
Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.恶性疟原虫二氢叶酸还原酶突变对乙胺嘧啶-WR99210组合产生抗性的相互冲突的要求。
Antimicrob Agents Chemother. 2007 Dec;51(12):4356-60. doi: 10.1128/AAC.00577-07. Epub 2007 Sep 17.
9
Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand.泰国间日疟原虫分离株对抗叶酸药物的敏感性及基因分析
Am J Trop Med Hyg. 2007 Jun;76(6):1057-65.
10
Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates.间日疟原虫:用于测量新鲜和冷冻保存分离株中氯喹敏感性的同位素、PicoGreen 和显微镜检测法。
Exp Parasitol. 2006 Sep;114(1):34-9. doi: 10.1016/j.exppara.2006.02.006. Epub 2006 Mar 20.